X-VAX TECHNOLOGY
X-Vax Technology is a biotechnology company focused on the preclinical and clinical development of vaccines against pathogens that cause mucosal infections such as herpes, influenza, tuberculosis and HIV, affecting hundreds of millions of people around the globe. They believe that inducing antibodies that mediate the killing of infected cells will provoke an entirely new and effective immune response โ so that they can finally beat these pathogens. The company was founded in 2015 and based in Jupiter, Florida.
X-VAX TECHNOLOGY
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Jupiter, Florida, United States
Country:
United States
Website Url:
http://www.x-vax.com
Total Employee:
11+
Status:
Active
Total Funding:
56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins
Similar Organizations
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Rapid Novor
Rapid Novor is a biotech company dedicated to advance next-generation protein sequencing technology.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vital Therapies
Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.
Current Employees Featured
Founder
Investors List
Johnson & Johnson Innovation โ JJDC
Johnson & Johnson Innovation โ JJDC investment in Series A - X-Vax Technology
Founders Fund
Founders Fund investment in Series A - X-Vax Technology
Adjuvant Capital
Adjuvant Capital investment in Series A - X-Vax Technology
Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. investment in Series A - X-Vax Technology
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - X-Vax Technology
Connectivity Ventures Fund
Connectivity Ventures Fund investment in Series A - X-Vax Technology
Helicase Venture
Helicase Venture investment in Series A - X-Vax Technology
Thynk Capital, LLC.
Thynk Capital, LLC. investment in Series A - X-Vax Technology
Official Site Inspections
http://www.x-vax.com Semrush global rank: 2.55 M Semrush visits lastest month: 6.91 K
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108

More informations about "X-Vax Technology"
X-Vax 2025 Company Profile: Valuation, Funding
X-Vax General Information Description. Operator of a biotechnology company intended to develop vaccines against pathogens acquired by a mucosal โฆSee details»
X-Vax Technology Prepares to Submit IND for Genital โฆ
May 19, 2021 X-Vax technology herpes vaccine . Based in Jupiter, Fla., X-Vax Technology is preparing to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its experimental herpes โฆSee details»
X-Vax Technology - Funding, Financials, Valuation & Investors
X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes. ... Experience the new Crunchbase, powered by AI . โฆSee details»
X-Vax Technology Inc - Company Profile and News
X-Vax Technology, Inc. operates as a biotechnology company. The Company develops and commercializes therapies and vaccines against pathogens acquired by mucosal infection such โฆSee details»
X-Vax Company Profile - Office Locations, Competitors, Revenue
X-Vax has 5 employees across 2 locations and $56 m in total funding,. See insights on X-Vax including office locations, competitors, revenue, financials, executives, subsidiaries and more โฆSee details»
X-Vax Technology Company Information - Funding, Investors, and โฆ
Get information on funding, investors, industries, and more for X-Vax Technology. See X-Vax Technology company profile and funding data.See details»
X-Vax | VentureRadar
Similar Companies: Rational Vaccines USA Privately Held We are an investigational-stage infectious disease company focused on combating all diseases resulting from herpes simplex โฆSee details»
X-Vax Technology Inc. - BioCentury Company Profiles - BCIQ
Jan 20, 2022 X-Vax Technology Inc. - BioCentury Company Profiles for the biopharma industrySee details»
X-Vax Technology, Inc. | Insights
Aug 12, 2019 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
X-Vax Company Information - Funding, Investors, and More
The company X-Vax has raised a total of $56m in funding over 1 rounds. Key Insights: X-Vax Series A round, July 2019: $56m; 2019. X-Vax Series A round, July 2019 $56m. Industries. X โฆSee details»
x-vax technology, inc. News & Press Releases | PR Newswire
Jul 23, 2019 Jul 21, 2021, 13:17 ET X-Vax Technology Appoints Varsha K. Jain, MD as Chief Clinical Development Officer . X-Vax Technology, Inc. (X-VAX®), a biotechnology company โฆSee details»
X-Vax Technology - Tech Stack, Apps, Patents & Trademarks
Jan 13, 2025 X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes. New. Resources. ... Experience the new โฆSee details»
Beating Herpes: Inside X-VAX's Vaccine Candidate - Bioprocess โฆ
May 18, 2021 The World Health Organization (WHO) reports that about half a billion people worldwideโincluding a full 13% of those aged 15 to 49โare living with genital herpes. ... X โฆSee details»
Research programme: Viral vaccines - X-Vax Technology
Viral, live vaccines are being developed by X-Vax Technology for the prevention of mucosal infections, including herpes simplex virus type 1 (HSV-1) and herpes Research programme: โฆSee details»
X-Vax Technology - Contacts, Employees, Board Members
Organization. X-Vax Technology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 6. Contacts 5. โฆSee details»
X-Vax Technology Inks $56M Series A - VC News Daily
X-Vax Technology (X-VAX ), a biotechnology company developing vaccines based on a new approach that mediates the killing of infected cells, today announced that it has raised $56 โฆSee details»
X-Vax Technology - Products, Competitors, Financials, Employees ...
X-Vax Technology is a biotech company focused on developing vaccines against pathogens acquired by mucosal infection, specifically in the healthcare industry. The company's main โฆSee details»
Elon Musk Says His AI Company Bought X at $33 Billion Valuation
2 days ago X has also integrated Grok, a chatbot developed by xAI, directly into the platform. The current iteration of the model, Grok 3, includes a search function as well as a feature โฆSee details»
X-Vax | VentureRadar
Website: https://x-vax.com/ Develops vaccines targeting mucosal infection pathogens, focusing on herpes prevention using genetically deleted glycoprotein D candidate ...See details»
X-VAX TECHNOLOGY, INC. Bankruptcy Filing
Nov 22, 2023 X-VAX TECHNOLOGY, INC. filed a 7 chapter bankruptcy in the District of Delaware bankruptcy court on November 22, 2023. This is a voluntary filing; it was assigned โฆSee details»